FDA Approves First Factor XIa Blood Thinner to Cut Repeat Strokes
Sunharbo, Bayer’s asundexian, is the first drug designed to prevent repeat strokes by blocking the clotting protein Factor XIa. In a large late-stage trial it cut the risk of a further stroke by 26 per cent.